𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Optimisation of containedNicotiana tabacumcultivation for the production of recombinant protein pharmaceuticals

✍ Scribed by Richard Colgan; Christopher J. Atkinson; Matthew Paul; Sally Hassan; Pascal M. W. Drake; Amy L. Sexton; Simon Santa-Cruz; David James; Keith Hamp; Colin Gutteridge; Julian K-C. Ma

Book ID
106550573
Publisher
Springer Netherlands
Year
2009
Tongue
English
Weight
375 KB
Volume
19
Category
Article
ISSN
0962-8819

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Pharmaceutical Biotechnology || Producti
Pharmaceutical Biotechnology || Production and Purification of Recombinant Proteins
✍ Crommelin, Daan J. A.; Sindelar, Robert D.; Meibohm, Bernd πŸ“‚ Article πŸ“… 2013 πŸ› Springer New York 🌐 English βš– 770 KB

This introductory text explains both the basic science and the applications of biotechnology-derived pharmaceuticals, with special emphasis on their clinical use. It serves as a complete one-stop source for undergraduate/graduate pharmacists, pharmaceutical science students, and for those in the pha

Applications of mass spectrometry for th
Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals
✍ Catherine A. Srebalus Barnes; Amareth Lim πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 365 KB

## Abstract Therapeutic proteins produced using recombinant DNA technologies are generally complex, heterogeneous, and subject to a variety of enzymatic or chemical modifications during expression, purification, and long‐term storage. The use of mass spectrometry (MS) for the evaluation of recombin